4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-22-034606
Director acquired 3,356 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Reasons Bryan M. Director | 2022-06-03 | Option exercise | +3,356 | 19,565 | D | ||
| Derivatives | |||||||
| Reasons Bryan M. Director | 2022-06-02 | Grant or award · Stock Option (Right to Buy) | +15,750 | 15,750 | D | ||
| Reasons Bryan M. Director | 2022-06-02 | Grant or award · Restricted Stock Units | +4,507 | 4,507 | D | ||
| Reasons Bryan M. Director | 2022-06-03 | Option exercise · Restricted Stock Units | −3,356 | 0 | D | ||
Loading xslF345X03/doc4.xml…